Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver Diseases.

Conclusion: There is a linear relationship between disease progression and expression level of miR-212 in the serum of HBV infected patients. This demonstrates that miR-212 plays a significant role in liver diseases. miR-212 is expected to be a new biomarker use in the diagnosis and assessment of patients with HBV-infection-related liver diseases. PMID: 31608838 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31608838?dopt=Abstract

Source: Current Drug Metabolism - October 10, 2019 Category: Drugs & Pharmacology Authors: Zhang Y, Xi H, Nie X, Yuan W, Zhang P, Lan N, Lu Y, Liu J Tags: Curr Drug Metab Source Type: research